Today's Wall Street Journal (page D1) discusses the new generation of drug-eluting cardiac stents coming from Boston Scientific, Medtronic, Johnson & Johnson and Abbott Labs awaiting FDA approval. Upon the FDA's OK, these more advanced, safer stents should result in new demand for SOTK's drug coating applications equipment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.